Which genomic test do you use when considering active surveillance in prostate cancer?

As a prologue, molecular expression features, often grouped into "panels" with mathematical models for outcome estimation, can be useful to help patients and clinicians determine whether historical (often still standard) clinicopathological features don't under- or over-estimate risk of clinical sig...